News & Events

Filter Year   Keywords   > Submit

Otsuka Pharmaceutical Announces Positive Topline Results from Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children with Attention-Deficit/Hyperactivity Disorder (ADHD)

27 / 10 / 2023

> Read More

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

10 / 04 / 2023

> Read More

 
Displaying 2 records